L eishmaniasis is a chronic disease caused by obligate intracellular protozoan parasites. There are more than 20 pathogenic species of the Leishmania parasite worldwide. The organisms are transmitted by approximately 70 species of hematophagous sand flies in the Phlebotomus and Lutzomyia genera. 1 In the New World (Western hemisphere),
Lutzomyia sand flies feed on and transmit Leishmania between various mammalian reservoirs, including wood rats, cotton rats, other rodents, opossums, and armadillos. [2] [3] [4] [5] [6] [7] [8] In the United States, leishmaniasis has also been documented in domesticated cats and dogs ( Table 1) .
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Leishmania species are classified as Old World or New World depending on the geographic region in which they primarily occur. Leishmania speciation helps to define the clinical subtype of disease (eTable in the Supplement) 1, 11, 13 and, therefore, expected severity, prognosis, and required treatment. In humans, leishmaniasis comprises a spectrum of disease with 3 major clinical subtypes: cutaneous, mucocutaneous, and visceral. Cutaneous leishmaniasis is the most common form of the disease worldwide. Mucocutaneous leishmaniasis is less common, occurring almost exclusively in the New World (Central America and South America). 13 Visceral disease, also known as kala-azar, is the most severe and persistent type of leishmaniasis and occurs primarily in the Old World. 14 In the United States, leishmaniasis is widely considered a disease of travelers. Numerous American health authorities echo similar statements: "The cases of leishmaniasis evaluated in the United States reflect travel and immigration patterns.… Almost all of the cases of leishmaniasis diagnosed in the United States are in people who became infected while traveling or living in other countries." 15 Medical literature and the most current editions of infectious disease, tropical medicine, dermatology, and other medical textbooks present leishmaniasis as a uniquely tropical disease. 1, 13, 14, [16] [17] [18] [19] [20] [21] [22] [23] [24] Published maps highlighting endemic regions of cutaneous leishmaniasis conspicuously exclude the United States ( Figure 1) . 13, 14, 18, 19, 25 The current American medical view of cutaneous leishmaniasis fails to take into account veterinary and environmental literature that has repeatedly demonstrated American endemicity of leishmaniasis, 10, 26 It is therefore not surprising that US physicians often consider a diagnosis of leishmaniasis only in returning vacationers, military service members, or immigrants from endemic regions. Yet over the past century, the incidence of autochthonous cases of cutaneous leishmaniasis in the United States has grown alongside vector and reservoir habitats, with more than 40 human cases reported in the literature since 1903. 2, 27, 32 In Texas, leishmaniasis has become so prevalent that it is now reportable to the Texas DSHS. In the absence of nationally reported data, however, assessment of leishmaniasis incidence and prevalence across the rest of the United States is speculative at best. The aim of this study is to evaluate the incidence of leishmaniasis in the United States over a 10-year period, with a focus on the relative frequency of autochthonous vs travelacquired cases.
Methods
Institutional review board exemption for this review of previously collected, deidentified demographic data was obtained from the University of North Texas Health Science Center in December 2014 and the Texas DSHS in June 2016. The Texas DSHS provided the deidentified demographics of all cases of leishmaniasis formally reported to it from 2007-when reporting became mandatory in Texas-through 2017. Cases of leishmaniasis reported by the laboratories of the authors and acknowledged contributors were diagnosed histopathologically by board-certified dermatopathologists from January 2007 through September 2017. Laboratory cases were identified within each laboratory by searching disease name (leishmaniasis) or International Classification of Diseases, 9th and 10th Revisions diagnostic codes in the respective laboratory information systems. The source laboratories accept specimens from varied medical subspecialties, including dermatology, primary care, surgery, podiatry, and dentistry. 
Meaning
Human cutaneous leishmaniasis appears to be endemic in the United States and is acquired endemically more frequently than it is via travel, which argues in favor of making it a federally reportable disease.
Deidentified demographics of all leishmaniasis cases were reviewed. The demographics collected for each case included the following, if available: patient age at diagnosis, sex, race, county of residence, date of leishmaniasis diagnosis, anatomic location of sampled lesion, relevant exposures, treatments undertaken, Leishmania speciation, whether disease was contracted within or outside of the country, and travel history outside of Texas and/ or the United States. Recorded travel history for each case was classified as either documentation of no history of travel outside of the United States within the past 10 years, positive history of travel outside of the United States within the past 10 years, or unknown or no documentation of travel history.
Results
Collection of histopathologically confirmed cases from defined data sources resulted in the identification of 75 total cases of leishmaniasis. Of these, 6 cases matched the demographics of those previously reported in the medical literature and were excluded from further analysis. 27, 33 Of the remaining 69 novel cases of leishmaniasis identified, 41 (59%) were autochthonous, occurring in patients with documentation of no history of travel outside of the United States ( Figure 2 ). The median age at diagnosis was 61 years (range, 3-89 years), and 28 (68%) of the endemic cases occurred in female patients. Cases of endemic leishmaniasis showed a predilection for areas of skin that are commonly exposed, with 20 (49%) cases diagnosed on the face, head, or neck, and 19 (46%) diagnosed on the upper extremities ( Table 2 ). All identified cases of endemic leishmaniasis were from Texas. Of these cases, only 14 (20%) were reported to the Texas DSHS as required by law. Twenty-two (32%) cases had documentation of Leishmania speciation performed by polymerase chain reaction, and in 100% of these cases the infectious organism was Leishmania mexicana ( Figure 3) .
Discussion
Our data demonstrate 4 major points: (1) cutaneous leishmaniasis appears to be endemic in humans in the southern United States; (2) in the southern United States, cutaneous leishmani- zoonotic transmission of leishmaniasis in an area far beyond the suspected range of natural disease. The subsequent additional diagnoses of autochthonous human leishmaniasis in further eastern and northern Texas suggest this suspicion may be correct. 26, 33 Because the habitat of N floridana extends from California to North Carolina, its relatively new status as a reservoir host extends the potential range for zoonotic transmission of L mexicana across nearly the entire southern United States, assuming presence of appropriate vectors. 35 These findings suggest a burgeoning public health concern, particularly in the setting of low clinical suspicion. 2 The
American medical profession's unfamiliarity with endemic leishmaniasis greatly decreases the likelihood of suspecting and diagnosing the disease. All North American physicians, not just those in Texas or the Southwest, must be clinically aware of endemic human leishmaniasis. Relegating discussion of cutaneous leishmaniasis to the tropical disease sections of medical literature limits sufficient training of American physicians in the widely varied clinical presentations of the disease. The photographs of Old World, mucocutaneous, and visceral leishmaniasis frequently presented in medical textbooks are often quite dramatic, with ulceration, deformation of tissue, and loss of chondrocutaneous landmarks. In contrast, American cases of leishmaniasis caused by L mexicana often present more subtly and may take myriad clinical forms, including that of a papular, nodular, or ulcerative dermatosis. Unsurprisingly, clinical recognition of endemic leishmaniasis remains low among American physicians: in this study, no confirmed cases of leishmaniasis were initially suspected as such by the clinician. North American dermatologists, family physicians, and other clinicians should keep leishmaniasis in mind when constructing clinical differential diagnoses for cutaneous lesions. When taking a biopsy of such lesions, including cutaneous leishmaniasis in the clinical differential diagnosis provided with the sample can be instructive to the evaluating dermatopathologist. Dermatopathologists and general pathologists must likewise be aware of the rising prevalence of endemic leishmaniasis in the United States. In our experience with consultation material of unrecognized cases of leishmaniasis, the original pathologic differential diagnosis often included acneiform eruptions, pseudolymphoma, juvenile xanthogranuloma, and squamous cell carcinoma, among others.
Teaching American physicians that cutaneous leishmaniasis is a tropical disease also limits their training in appropriate treatment of the disease. The majority of patients with cutaneous leishmaniasis caused by L mexicana-as all endemic American cases thus far have been-do not require systemic therapy. These cases may be treated with minor, office-based procedures, such as cryotherapy or brachytherapy, and moni- tored clinically because there is no risk of progression to visceral leishmaniasis. 36, 37 American physicians who are taught that leishmaniasis is a life-threatening tropical disease requiring toxic systemic therapy (eg, pentavalent antimonials) could, after receiving a histopathologic diagnosis of leishmaniasis in their domestic patient, subject that patient to unnecessary and harmful systemic medications. Despite a lack of national reporting requirements, leishmaniasis has been a reportable disease in Texas since 2007. Texas state law requires the reporting of leishmaniasis cases to the Texas DSHS within 1 week of diagnosis. The Texas state law is broad in its requirements for reporting infectious diseases: clinicians, hospitals, laboratories, schools, parents, first responders, or anyone else who may become aware of a notifiable condition is compelled by law to report it to the DSHS. 38 Having numerous designated reporters theoretically reduces the risk of failing to identify a case; however, of the leishmaniasis cases identified in the current study, only 20% were reported to the DSHS as required by state law.
Low compliance with mandatory reporting illustrates the medical profession's lack of awareness regarding human leishmaniasis, even in Texas, where the disease is common enough to be reportable. Throughout the rest of the United States, awareness and diagnosis of human leishmaniasis is likely even lower. Climate models suggest that the habitats of leishmaniasis vectors and reservoirs will continue to spread across the United States in response to climate change, exposing more Americans each year to endemic leishmaniasis. However, lack of a federal reporting requirement makes it impossible to know and track the true prevalence of cutaneous leishmaniasis in the United States.
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Limitations
Limitations of this study include the geographic recruitment area of the source laboratories. Although all laboratories used in this study accept specimens from across the United States, the physical laboratories are located within Texas and receive a majority of their specimens locally. It would be beneficial to look at leishmaniasis cases reported by laboratories in other geographic regions of the United States. Furthermore, because leishmaniasis is not a federally reportable disease, reported data on disease cases are not available for states outside of Texas. Requiring federal reporting of cases of human leishmaniasis would allow discernment of true disease incidence across the United States. Well-publicized federal reporting requirements would also increase clinical awareness of and suspicion for endemic disease among American physicians.
Conclusions
Cutaneous human leishmaniasis appears to be endemic in the United States. These data show that, at least in Texas, endemic human leishmaniasis is currently diagnosed more commonly in the United States than is travel-acquired disease. Including this study, there have now been more than 80 published cases of endemic human leishmaniasis in the United States. But with medical literature continuing to discuss leishmaniasis as an exotic illness, physician awareness of endemic disease remains low, as does adherence to state reporting requirements. The prevalence of endemic human leishmaniasis in North America is therefore likely even higher than reported here, but it can only be accurately tracked if leishmaniasis is made federally reportable. Ecologic modeling suggests that the habitats of leishmaniasis vectors and reservoirs may extend as far north as the Canadian border by 2050. We thus propose institution of requisite federal reporting for any human cases of cutaneous leishmaniasis. In such cases, North American physicians have 2 main categories of responsibility: (1) to recognize, diagnose, and treat the disease appropriately; and (2) to report the condition to the applicable local, state, or federal authorities. Labeling leishmaniasis as an endemic North American disease will greatly increase awareness of the disease in the medical community, encouraging clinical suspicion and timely diagnosis, proper reporting, and safe and appropriate treatment. This, coupled with mandated federal reporting, will equip the United States to better identify human cutaneous leishmaniasis and track disease prevalence over time.
